Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Achieve Life Sciences Inc
(NQ:
ACHV
)
6.280
+0.630 (+11.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
407,284
Open
5.710
Bid (Size)
6.230 (76)
Ask (Size)
6.690 (2)
Prev. Close
5.650
Today's Range
5.700 - 6.500
52wk Range
2.000 - 10.30
Shares Outstanding
18,040,760
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 23, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 23, 2023
Via
Benzinga
Performance
YTD
+148.22%
+148.22%
1 Month
-24.25%
-24.25%
3 Month
+27.38%
+27.38%
6 Month
+118.82%
+118.82%
1 Year
-10.16%
-10.16%
More News
Read More
Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial
May 23, 2023
Via
Benzinga
Recap: Achieve Life Sciences Q1 Earnings
May 09, 2023
Via
Benzinga
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
March 29, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences's Earnings: A Preview
March 15, 2023
Via
Benzinga
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
March 08, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
March 03, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday
May 23, 2023
Via
Benzinga
Achieve Life Sciences Inc. (NASDAQ: ACHV) Climbs to New 52-Week High
April 26, 2023
Via
Investor Brand Network
Want To Quit Smoking? Achieve Life Sciences Reports Successful E-Cigarette Cessation Benefit With Cytisinicline Treatment
April 20, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Collapse
March 31, 2023
Via
Benzinga
Achieve Life Sciences Announces Refresh to Board of Directors
March 30, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
March 02, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Award
March 17, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
February 07, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
February 02, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Award
January 27, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
January 23, 2023
Via
Benzinga
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
January 09, 2023
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
December 21, 2022
From
Achieve Life Sciences
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 22, 2022
Via
Benzinga
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
November 22, 2022
Via
Benzinga
Achieve Life Sciences Announces Private Placement of $18.9 Million
November 15, 2022
From
Achieve Life Sciences
Via
GlobeNewswire
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
November 08, 2022
From
Achieve Life Sciences
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.